Radio and PodcastLive Radio & PodcastsOpening Radio and Podcast...
Radio and PodcastLive Radio & PodcastsFetching podcast shows and categories...
Radio and PodcastLive Radio & PodcastsFetching podcast episodes...
A podcast from one of the world's top cancer journals that includes highlights from the current issue and an in-depth interview with a research expert on an important topic of the day
A podcast from one of the world's top cancer journals that includes highlights from the current issue and an in-depth interview with a resea...
Dr. Eric Winer discusses his editorial, “Adjuvant Chemotherapy for ER+ Breast Cancer: A Sea Change is Underway,” published in JNCI (December...
JNCI author Dr. Kurian explains her recent paper in JNCI.
JNCI author Dr. Kurian explains her recent paper in JNCI.
Author interview with Dr. Dawn L. Hershman
A podcast with JNCI author Daniel Joben.
Dr. Ashish Deshmukh and Dr, Anna Likhacheva discusses their recent paper, “Cost-Effectiveness Analysis Comparing Conventional, Hypofractiona...
A podcast from one of the world's top cancer journals that includes highlights from the current issue and an in-depth interview with a resea...
A JNCI Podcast with Curtis Harris
Dr. Judy Garber, of the Dana Farber Cancer Institute in Boston, discusses how family cancer history should be integrated into personalized p...
Dr. Avrum Spira discusses his recent paper, " Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection...
Mohammad Asim discusses the use of choline kinase alpha as an androgen receptor chaperone and prostate cancer therapeutic target
Lapo Sali discusses reduced and full-preparation CT colonography, fecal immunochemical test, and colonoscopy for population screening of col...
Erika Loftfield discusses how drinking coffee may be associated with a lower risk of malignant melanoma
Carrie Bennette discusses factors predicting low patient accrual in cancer clinical trials
Leroy Hood discusses the future of cancer research
Vincent Devita discusses the future of cancer research
Heinz-Josef Lenz discusses his study about using the location of primary tumors as a prognostic factor in metastatic colorectal cancer
David Gerber discusses the effects of prior cancer on outcomes in advanced lung cancer
Martine Moossdorff talks about creating a consensus group of international breast cancer experts to come up with definitions for certain bre...
DeAnn Lazovich discusses exposure to indoor tanning and melanoma risk
Martin Tammemägi discusses the impact of lung cancer screening results on smoking cessation
Khalid Shah discusses his study on stem cells
Paul Frankel discusses baseline selenium and prostate cancer risk
Isra G. Levy M.B., BCh., MSc., talks about the health risks and benefits of aspirin use.
Dr. Lesley Rushton discusses how miners exposed to high levels of diesel exhaust in various mining facilities in the U.S. have a higher risk...
Listen to summaries of the studies and news stories from Issue 12.
Listen to summaries of the studies and news stories from Issue 11.
Listen to summaries of the studies and news stories from Issue 10.
Dr. Jeffrey Schlom talks about therapeutic cancer vaccines
Dr. Michael Gnant of the Medical University of Vienna discusses data showing positive results on zoledronic acid and endocrine therapy for p...
Summaries of the News Stories from JNCI Volume 103 Issue 24.
Summaries of the News Stories from JNCI Volume 103 Issue 23.
Dr. Douglas McNeel discusses early stage studies on DNA vaccines for castrate resistant prostate cancer ahead of his presentation of the stu...
Dr. Douglas McNeel discusses early stage studies on DNA vaccines for castrate resistant prostate cancer ahead of his presentation of the stu...
Summaries of the News Stories from JNCI Volume 103 Issue 21.
Dr. Ole-Petter Hamnvik discusses antineoplastic agents such as immunotherapies and targeted therapies that specifically target signaling pat...
Dr. Chris Parker, lead investigator of the international ALSYMPCA trial of radium 223 (Alpharadin) for bone metastases in advanced prostate...
Dr. Gordon Mills elaborates on his lecture on molecular personalized medicine at the recent ECCO-ESMO Cancer Congress in Stockholm.
Dr. Eduardo Franco discusses a study showing that one and two doses of HPV vaccines are just as effective as three doses for decreasing the...
Dr. Kathy Helzlsouer, of the Prevention and Research Center at Mercy Medical Center in Baltimore, discusses breast cancer risk prediction mo...
Dr. Jennifer Vidrine, of the University of Texas MD Anderson Cancer Center, discusses active and passive recruitment methods for smoking qui...
Dr. Joan Warren, of the National Cancer Institute, conducted a study that compared end-of-life care for lung cancer patients in Ontario and...
Dr. Judy Garber, of the Dana Farber Cancer Institute in Boston, discusses how family cancer history should be integrated into personalized p...
Dr. Lisa Kachnic, of Boston University Medical Center, discusses how the growing usage of IMRT, or intensity-modulated radiation therapy, fo...
Dr. Brenda Edward, one of the authors of the Annual Report to the Nation on cancer trends in the U.S., discusses this year's report, which f...
Dr. Otis Brawley discusses a study on PSA velocity showing that using PSA velocity as a prostate cancer marker would not improve patient out...
Dr. Interview with Dr. Philip Glass
Dr. Patricia Ganz of UCLA discusses a review of breast cancer clinical trials that included quality of life measures as endpoints.
Dr. Matthew Mealiffe discusses a cohort study from the Women's Health Initiative that combines the usage of the Gail model and SNPs (single...